Cyclerion Therapeutics, Inc. ( CYCN) - Stock Earnings
Stock symbol CYCN is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker CYCN was renamed to
KRSA
effective 2026-09-09.
CYCN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
CYCN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -799000 USD | 1.0 million USD |
| 2026Q1 | -3.2 million USD | — USD |
| 2026Q2 | -1.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CYCN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.3 million USD | — USD |
| 2024 | -3.1 million USD | 2.0 million USD |
| 2025 | -3.5 million USD | 2.1 million USD |
| 2026 Est. | — | — |
CYCN
Price: $23.52
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 146600
Market Capitalization: 23.2 million